When and how to include vulnerable subjects in clinical trials.
There has been a good deal of discussion in the literature regarding which subjects are vulnerable in the context of clinical trials. There has been significantly less discussion regarding when and how to include vulnerable subjects in clinical trials. This lack of guidance is a particular problem f...
| Publicado en: | Clinical Trials Vol. 17; no. 6; pp. 696 - 703 |
|---|---|
| Autor principal: | |
| Formato: | algorithm Journal Article |
| Publicado: |
Sage Publications, Ltd.
Dec2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |